| Hypertension status | RMST Mean (CI) | RMST Difference (CI) | RMTL Mean (CI) | RMTL Ratios (CI) | RMST Mean (CI) | RMST Difference (CI) | RMTL Mean (CI) | RMTL Ratios (CI) |
---|---|---|---|---|---|---|---|---|---|
Multi-state model 1 | |||||||||
Transition | Â | According to JNC7 | According to the 2017 ACC/AHA | ||||||
CVD-free to non-fatal CVD | Normotensives | 13.6 (13.4–13.7) | −0.9 (−1.1,− 0.6)* | 1.4 (1.2–1.5) | 1.6 (1.4–1.9)* | 13.7 (13.4–13.9) | -0.6 (− 0.8,-0.3)* | 1.3 (1.1–1.5) | 1.4 (1.2, 1.7)* |
Hypertensives | 12.7 (12.5–13.0) | 2.3 (1.9–2.4) | 13.1 (12.9–13.2) | 1.9 (1.7–2.1) | |||||
CVD-free to CVD death | Normotensives | 14.7 (14.6–14.8) | −0.5 (−0.7,− 0.3)* | 0.3 (0.1–0.4) | 2.6 (2.1–4.2)* | 14.7 (14.6–14.8) | -0.3 (− 0.4,− 0.1)* | 0.3 (0.1–0.3) | 2.0 (1.3, 3.1) †|
Hypertensives | 14.2 (14.1–14.3) | 0.8 (0.6–0.9) | 14.4 (14.3–14.5) | 0.6 (0.4–0.6) | |||||
Non-fatal CVD to CVD death | Normotensives | 10.6 (10.1–11.0) | −0.1 (− 0.7, 0.5) | 1.4 (0.9–1.9) | 1.1 (0.7–1.6) | 10.6 (9.7–11.0) | -0.1 (− 0.5, 0.9) | 1.4 (0.6–1.9) | 1.1 (0.5, 1.4) |
Hypertensives | 10.5(10.0–10.9) | 1.5 (1.1–1.9) | 10.5(10.2–10.9) | 1.5 (1.1–1.8) | |||||
Multi-state model 2 | |||||||||
CVD-free to non-fatal CVD | Normotensives | 13.6 (13.5–13.8) | − 0.9 (−1.1,− 0.6)* | 1.4 (1.2–1.5) | 1.6 (1.4–1.9)* | 13.7 (13.5, 13.9) | -0.6 (− 0.8,-0.3)* | 1.3 (1.1, 1.5) | 1.4 (1.2, 1.7)* |
Hypertensives | 12.7 (12.5–13.0) | 2.2 (1.9–2.4) | 13.1 (12.9, 13.2) | 1.9 (1.7, 2.1) | |||||
CVD-free to all-cause death | Normotensives | 14.2 (14.1–14.3) | −0.7 (−0.9,-0.5)* | 0.8 (0.6–0.8) | 1.9 (1.5–2.3)* | 14.2 (14.0, 14.3) | −0.4 (− 0.5,-0.1)†| 0.8 (0.6, 0.9) | 1.5 (1.1, 1.8)†|
Hypertensives | 13.5 (13.3–13.7) | 1.5 (1.2–1.6) | 13.8 (13.6, 13.9) | 1.2 (1.0, 1.3) | |||||
Non-fatal CVD to all-cause death | Normotensives | 9.7 (9.2–10.3) | −0.3 (−1.1, 0.3) | 2.3 (1.7–2.8) | 1.1 (0.8–1.5) | 9.51 (8.7, 10.2) | 0.01 (−0.8, 0.9) | 2.47 (1.8, 3.4) | 1.01 (0.9, 1.1) |
Hypertensives | 9.4 (8.8–9.8) | 2.6 (2.1–3.1) | 9.50 (9.1–10.0) | 2.49 (2.0, 2.8) |